Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386:154–62.

Article  PubMed  PubMed Central  Google Scholar 

Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37:371–8.

Article  CAS  PubMed  Google Scholar 

Hsu JC, Freeman JV. Underuse of vitamin K antagonist and direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: a contemporary review. Clin Pharmacol Ther. 2018;104:301–10.

Article  CAS  PubMed  Google Scholar 

Chan PS, Maddox TM, Tang F, Spinler S, Spertus JA. Practice-level variation in warfarin use among outpatients with atrial fibrillation (from the NCDR PINNACLE program). Am J Cardiol. 2011;108:1136–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74:511–44.

Article  CAS  PubMed  Google Scholar 

•• Chung MK, Fagerlin A, Wang PJ, et al (2021) Shared decision making in cardiac electrophysiology procedures and arrhythmia management. circulation: arrhythmia and electrophysiology. https://doi.org/10.1161/circep.121.007958. Explanation of importance: Chung et al. detail currently available shared decision-making (SDM) tools in electrophysiology and arrhythmia management. The authors outline how decision aids were developed to enhance the effectiveness of patient-provider communication as they take into consideration patient preferences. However, there remains a gap in research on the effectiveness and outcomes of using decision aids in the field of electrophysiology. The authors argue how future research should focus on evaluating the effectiveness of SDM in a diverse set of patient populations including those with low health literacy and patients from multiple racial/ ethnic groups.

Stewart S, Ball J, Horowitz JD, et al. Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial. Lancet. 2015;385:775–84.

Article  PubMed  Google Scholar 

•• Hendriks, De Wit, Crijns Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients …. Eur. Heart J. Cardiovasc. Imaging. Explanation of importance: This methodology article highlights the rationale for and the role of education in empowering individuals with atrial fibrillation (AF) to self-manage their condition. Their focus is the Home-Based Education and Learning Program in AF (HELP-AF) randomized controlled trial that delivers 4 key messages to patients in the comfort of their homes. The messages nudge patients to take their AF medications to reduce their stroke risk. The authors also emphasize that the role of education on AF patient outcomes remains unclear and that more research needs to be carried out in this area.

Carter L, Gardner M, Magee K, Fearon A, Morgulis I, Doucette S, Sapp JL, Gray C, Abdelwahab A, Parkash R. An integrated management approach to atrial fibrillation. J Am Heart Assoc. 2016. https://doi.org/10.1161/JAHA.115.002950.

Article  PubMed  PubMed Central  Google Scholar 

Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJG. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest. 2010;137:263–72.

Article  PubMed  Google Scholar 

Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.

Article  CAS  PubMed  Google Scholar 

Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.

Article  CAS  PubMed  Google Scholar 

Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–92.

Article  CAS  PubMed  Google Scholar 

Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093–104.

Article  CAS  PubMed  Google Scholar 

January CT, Samuel Wann L, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019. https://doi.org/10.1161/cir.0000000000000665.

Article  PubMed  Google Scholar 

Holmes DR Jr, Doshi SK, Kar S, Price MJ, Sanchez JM, Sievert H, Valderrabano M, Reddy VY. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J Am Coll Cardiol. 2015;65:2614–23.

Article  PubMed  Google Scholar 

Yao X, Gersh BJ, Holmes DR Jr, Melduni RM, Johnsrud DO, Sangaralingham LR, Shah ND, Noseworthy PA. Association of surgical left atrial appendage occlusion with subsequent stroke and mortality among patients undergoing cardiac surgery. JAMA. 2018;319:2116–26.

Article  PubMed  PubMed Central  Google Scholar 

January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: a report of the American college of cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74:104–32.

Article  PubMed  Google Scholar 

Siddiqi TJ, Usman MS, Shahid I, Ahmed J, Khan SU, Ya’qoub L, Rihal CS, Alkhouli M. Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis. Eur J Prev Cardiol. 2022;29:625–31.

Article  PubMed  Google Scholar 

Leyden JM, Kleinig TJ, Newbury J, et al. Adelaide stroke incidence study: declining stroke rates but many preventable cardioembolic strokes. Stroke. 2013;44:1226–31.

Article  PubMed  Google Scholar 

Kakkar AK, Mueller I, Bassand J-P, et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One. 2013;8: e63479.

Article  PubMed  PubMed Central  Google Scholar 

Hsu JC, Maddox TM, Kennedy KF, Katz DF, Marzec LN, Lubitz SA, Gehi AK, Turakhia MP, Marcus GM. Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk: insights from the NCDR PINNACLE Registry. JAMA Cardiol. 2016;1:55–62.

Article  PubMed  Google Scholar 

Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, et al. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: Baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace. 2014;16:308–19. https://doi.org/10.1093/europace/eut373.

Article  PubMed  Google Scholar 

Pham PN, Brown JD. Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter? BMC Cardiovasc Disord. 2019;19:64.

Article  PubMed  PubMed Central  Google Scholar 

Tereshchenko LG, Henrikson CA, Cigarroa J, Steinberg JS. Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis. J Am Heart Assoc. 2016;5(5):e003206. https://doi.org/10.1161/JAHA.116.003206. 

Freedman B, Potpara TS, Lip GYH. Stroke prevention in atrial fibrillation. Lancet. 2016;388:806–17.

Article  PubMed  Google Scholar 

Själander S, Själander A, Svensson PJ, Friberg L. Atrial fibrillation patients do not benefit from acetylsalicylic acid. Europace. 2014;16:631–8.

Article  PubMed  Google Scholar 

Ben Freedman S, Gersh BJ, Lip GYH. Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation. Eur Heart J. 2015;36:653–6.

Article  CAS  PubMed  Google Scholar 

Hsu JC, Maddox TM, Kennedy K, Katz DF, Marzec LN, Lubitz SA, Gehi AK, Turakhia MP, Marcus GM. Aspirin Instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke. J Am Coll Cardiol. 2016;67:2913–23.

Article  CAS  PubMed  Google Scholar 

Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321:1261–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021;384:305–15.

Article  CAS  PubMed  Google Scholar 

Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20:e1–160.

Article  PubMed  Google Scholar 

Verma A, Ha ACT, Kirchhof P, et al. The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial. Am Heart J. 2018;197:124–32.

Article  CAS  PubMed  Google Scholar 

Carter AR, Gill D, Davies NM, et al. Understanding the consequences of education inequality on cardiovascular disease: mendelian randomisation study. BMJ. 2019;365: l1855.

Article  PubMed  PubMed Central  Google Scholar 

Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011;155:97–107.

Article  PubMed  Google Scholar 

Edwards M, Wood F, Davies M, Edwards A. The development of health literacy in patients with a long-term health condition: the health literacy pathway model. BMC Public Health. 2012;12:130.

Article  PubMed  PubMed Central  Google Scholar 

Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int. 2000;15:259–67.

Article  Google Scholar 

Pleasant A. Health literacy: an opportunity to improve individual, community, and global health. New Dir Adult Contin Educ. 2011;2011:43–53.

Article  Google Scholar 

Sørensen K, Van den Broucke S, Fullam J, Doyle G, Pelikan J, Slonska Z, Brand H, (HLS-EU) Consortium Health Literacy Project European. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health. 2012;12:80.